Atypical hemolytic uremic syndrome after childbirth: a case report.

Atypical hemolytic uremic syndrome (HUS) CFHR3-CFHR1 case report copy number gain pregnancy

Journal

Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978

Informations de publication

Date de publication:
Jan 2021
Historique:
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 9 2 2021
Statut: ppublish

Résumé

We report a case of atypical hemolytic uremic syndrome (HUS) that occurred after childbirth. A 33-year-old female was admitted to the emergency room, complaining of abdominal pain six days after giving birth to twins. The patient was diagnosed with hemoperitoneum due to hepatic hemangioma rupture and a left lateral hepatectomy was performed. Angioembolization was performed for the accompanying uterine artery bleeding. After that, her kidney function worsened after the 12th day postpartum. Microangiopathic anemia, thrombocytopenia and renal dysfunction were observed. Shiga toxin-producing Escherichia coli was negative in the stool. Plasma ADMATS 13 activity was normal. After transfer to the nephrology department with suspected atypical HUS, the patient underwent fresh frozen plasma (FFP) transfusion with three hemodialysis sessions. The patient improved without additional dialysis, but a renal biopsy was performed because of persistent proteinuria. Renal pathologic findings were compatible with thrombotic microangiopathy. A genetic test for atypical HUS revealed variants of uncertain significance in the complement factor H related (CFHR) 4 gene and the presence of CFHR3-CFHR1 copy number gain. The

Identifiants

pubmed: 33553372
doi: 10.21037/atm-20-3789
pii: atm-09-01-79
pmc: PMC7859817
doi:

Types de publication

Case Reports

Langues

eng

Pagination

79

Informations de copyright

2021 Annals of Translational Medicine. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3789). The authors have no conflicts of interest to declare.

Références

Glob Adv Health Med. 2013 Sep;2(5):38-43
pubmed: 24416692
J Am Soc Nephrol. 2015 Jan;26(1):209-19
pubmed: 24904082
CEN Case Rep. 2019 May;8(2):139-143
pubmed: 30715674
Transfus Apher Sci. 2016 Apr;54(2):199-202
pubmed: 27158062
Mol Immunol. 2013 Dec 15;56(3):170-80
pubmed: 23830046
J Am Soc Nephrol. 2010 May;21(5):859-67
pubmed: 20203157
Korean J Intern Med. 2020 Jan;35(1):25-40
pubmed: 31935318
Am J Kidney Dis. 2018 Sep;72(3):451-456
pubmed: 29331477
Pediatr Nephrol. 2013 Nov;28(11):2221-5
pubmed: 23880784

Auteurs

Hong Sang Choi (HS)

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Jae Won Yun (JW)

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul, Korea.

Hee-Jin Kim (HJ)

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Doyeun Oh (D)

Department of Internal Medicine, School of Medicine, CHA University, School of Medicine, Seongnam, Korea.

Nah Ihm Kim (NI)

Department of Pathology, Chonnam National University Medical School, Gwangju, Korea.

Chang Seong Kim (CS)

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Seong Kwon Ma (SK)

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Soo Wan Kim (SW)

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Eun Hui Bae (EH)

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Classifications MeSH